Income Statement QuidelOrtho Corporation

Equities

QDEL

US2197981051

Advanced Medical Equipment & Technology

Market Closed - Nasdaq Other stock markets 20:00:00 13/03/2026 GMT			5-day change	1st Jan Change
17.10 ^USD	-4.58%		-17.91%	-40.13%

02-16	QuidelOrtho Corporation Enters Strategic Supply Agreement to Expand Global Immunoassay Portfolio	CI
02-13	Joseph M. Busky to Retire as Principal Financial Officer of Quidelortho Corporation, Effective as of June 30, 2026	CI

0a09d4e9df918ed6405135.lTXQ1jWvdybs5RFVOg8yhBZsVlJplCfYq305ZYpAAqk.3Q2ykwbeGWPBpmQ7dkIG8kUZMicD5RK7-ApRB_oYb-L_UuP7YJY0ZIGsUA

Published financial data: QUIDELORTHO CORPORATION

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2021	2022	2023	2024	2025
Revenues	1.7B	3.27B	3B	2.78B	2.73B
Total Revenues	1.7B	3.27B	3B	2.78B	2.73B
Cost of Goods Sold, Total	428M	1.33B	1.5B	1.5B	1.45B
Gross Profit	1.27B	1.94B	1.49B	1.29B	1.28B
Selling General & Admin Expenses, Total	259M	621M	763M	767M	746M
R&D Expenses	95.7M	190M	247M	219M	186M
Amortization of Goodwill and Intangible Assets - (IS)	-	132M	205M	203M	189M
Other Operating Expenses	-	-	-	20M	32.7M
Other Operating Expenses, Total	355M	944M	1.21B	1.21B	1.15B
Operating Income	916M	992M	280M	77.6M	124M
Interest Expense, Total	-5.71M	-76.6M	-182M	-192M	-188M
Interest And Investment Income	-	1.3M	5.5M	2.6M	2.2M
Net Interest Expenses	-5.71M	-75.3M	-177M	-189M	-186M
Currency Exchange Gains (Loss)	-	-	-	-	10.7M
Other Non Operating Income (Expenses)	-	-8.5M	8.5M	18.3M	-8.5M
EBT, Excl. Unusual Items	910M	908M	111M	-93M	-59.8M
Restructuring Charges	-	-	-	-	-174M
Merger & Related Restructuring Charges	-9.56M	-136M	-113M	-127M	-89.3M
Impairment of Goodwill	-	-	-	-1.82B	-701M
Asset Writedown	-	-	-	-56.9M	-13.5M
Other Unusual Items	-217K	-36.3M	-27.1M	-31.8M	-70.1M
EBT, Incl. Unusual Items	900M	736M	-29.1M	-2.13B	-1.11B
Income Tax Expense	196M	187M	-19M	-79.5M	24.1M
Earnings From Continuing Operations	704M	549M	-10.1M	-2.05B	-1.13B
Net Income to Company	704M	549M	-10.1M	-2.05B	-1.13B
Net Income - (IS)	704M	549M	-10.1M	-2.05B	-1.13B
Net Income to Common Incl Extra Items	704M	549M	-10.1M	-2.05B	-1.13B
Net Income to Common Excl. Extra Items	704M	549M	-10.1M	-2.05B	-1.13B
Per Share Items
Net EPS - Basic	16.74	9.66	-0.15	-30.54	-16.69
Basic EPS - Continuing Operations	16.74	9.66	-0.15	-30.54	-16.69
Basic Weighted Average Shares Outstanding	42.08M	56.8M	66.8M	67.2M	67.8M
Net EPS - Diluted	16.43	9.56	-0.15	-30.54	-16.69
Diluted EPS - Continuing Operations	16.43	9.56	-0.15	-30.54	-16.69
Diluted Weighted Average Shares Outstanding	42.87M	57.4M	66.8M	67.2M	67.8M
Normalized Basic EPS	13.52	9.99	1.04	-0.86	-0.55
Normalized Diluted EPS	13.27	9.89	1.04	-0.86	-0.55
Supplemental Items
EBITDA	969M	1.27B	736M	528M	562M
EBITA	942M	1.12B	484M	278M	309M
EBIT	916M	992M	280M	77.6M	124M
EBITDAR	985M	1.31B	784M	582M	609M
Effective Tax Rate - (Ratio)	21.78	25.44	65.29	3.73	-2.18
Current Domestic Taxes	191M	211M	-50.9M	3.8M	-900K
Current Foreign Taxes	2.29M	17.6M	36.4M	22.1M	24.9M
Total Current Taxes	193M	229M	-14.5M	25.9M	24M
Deferred Domestic Taxes	4.63M	-41.2M	4.9M	-130M	-4.3M
Deferred Foreign Taxes	-1.99M	-200K	-9.4M	24.5M	4.4M
Total Deferred Taxes	2.64M	-41.4M	-4.5M	-105M	100K
Normalized Net Income	569M	568M	69.62M	-58.12M	-37.38M
Interest on Long-Term Debt	1.36M	76.6M	182M	192M	188M
Non-Cash Pension Expense	-	1.4M	2.5M	2.8M	2.3M
Supplemental Operating Expense Items
Advertising Expense	13.7M	26.8M	15.1M	6.2M	8.9M
Selling and Marketing Expenses	175M	26.8M	15.1M	6.2M	8.9M
General and Administrative Expenses	84.03M	-	-	-	-
Research And Development Expense From Footnotes	96.7M	191M	247M	221M	190M
Net Rental Expense, Total	15.36M	32M	48.2M	53.6M	47.3M
Imputed Operating Lease Interest Expense	5.66M	13.11M	25.68M	30.97M	25.68M
Imputed Operating Lease Depreciation	9.7M	18.89M	22.52M	22.63M	21.62M
Stock-Based Comp., COGS (Total)	2.66M	2.9M	4.3M	5.5M	5.9M
Stock-Based Comp., R&D Exp. (Total)	4.43M	4.9M	4.9M	3.4M	2.9M
Stock-Based Comp., S&M Exp. (Total)	6.44M	-	-	-	-
Stock-Based Comp., G&A Exp. (Total)	11.87M	-	-	-	-
Stock-Based Comp., SG&A Exp. (Total)	-	27.4M	37.7M	26M	32.9M
Stock-Based Comp., Other (Total)	-	30.4M	16.9M	7.5M	3.8M
Total Stock-Based Compensation	25.41M	65.6M	63.8M	42.4M	45.5M

Fiscal Period: December	2021	2022	2023	2024	2025
Assets
Cash And Equivalents	803M	293M	119M	98.3M	170M
Short Term Investments	25.76M	52.1M	48.4M	-	-
Trading Asset Securities, Total	-	15.9M	200K	1.3M	300K
Total Cash And Short Term Investments	829M	361M	168M	99.6M	170M
Accounts Receivable, Total	378M	504M	350M	315M	452M
Other Receivables	15.88M	82.9M	139M	136M	120M
Total Receivables	394M	586M	488M	451M	572M
Inventory	199M	524M	578M	534M	578M
Prepaid Expenses	14.6M	96.7M	67M	77.3M	53.9M
Other Current Assets, Total	4.59M	7M	9.8M	57M	74M
Total Current Assets	1.44B	1.58B	1.31B	1.22B	1.45B
Gross Property Plant And Equipment	617M	1.8B	2.13B	2.28B	2.46B
Accumulated Depreciation	-140M	-278M	-521M	-726M	-945M
Net Property Plant And Equipment	477M	1.52B	1.61B	1.55B	1.51B
Long-term Investments	37.85M	21M	7.4M	-	-
Goodwill	337M	2.48B	2.49B	650M	-
Other Intangibles, Total	98.66M	3.12B	2.93B	2.74B	2.56B
Accounts Receivable Long-Term	-	6.8M	-	-	-
Deferred Tax Assets Long-Term	20.09M	16.4M	25.9M	-	-
Deferred Charges Long-Term	-	3.5M	-	-	-
Other Long-Term Assets, Total	19.62M	112M	180M	271M	244M
Total Assets	2.43B	8.86B	8.56B	6.42B	5.77B
Liabilities
Accounts Payable, Total	101M	283M	295M	246M	279M
Accrued Expenses, Total	66.52M	204M	197M	244M	291M
Short-term Borrowings	-	-	-	198M	83M
Current Portion of Long-Term Debt	-	208M	140M	144M	95.3M
Current Portion of Leases	10.31M	24.4M	26.7M	31.1M	29.3M
Current Income Taxes Payable	66.94M	51.6M	11.1M	5.4M	11.5M
Unearned Revenue Current, Total	1.92M	76.4M	36.8M	33.5M	37.8M
Other Current Liabilities	76.33M	160M	128M	96.8M	138M
Total Current Liabilities	324M	1.01B	834M	999M	966M
Long-Term Debt	-	2.43B	2.28B	2.13B	2.49B
Long-Term Leases	129M	187M	173M	175M	156M
Unearned Revenue Non Current	-	9.4M	13.9M	17.3M	16.9M
Deferred Tax Liability Non Current	-	213M	192M	76.5M	90M
Other Non Current Liabilities	48.58M	72.3M	62.8M	38M	130M
Total Liabilities	501M	3.92B	3.56B	3.44B	3.85B
Common Stock, Total	42K	-	100K	100K	100K
Additional Paid In Capital	280M	2.8B	2.85B	2.88B	2.93B
Retained Earnings	1.65B	2.2B	2.19B	136M	-996M
Comprehensive Income and Other	355K	-67.6M	-30M	-36.2M	-15.4M
Total Common Equity	1.93B	4.93B	5.01B	2.98B	1.92B
Total Equity	1.93B	4.93B	5.01B	2.98B	1.92B
Total Liabilities And Equity	2.43B	8.86B	8.56B	6.42B	5.77B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	41.78M	66.51M	66.85M	67.45M	68.08M
ECS Total Common Shares Outstanding	41.69M	66.4M	66.7M	67.3M	67.9M
Book Value / Share	46.28	74.32	75.05	44.35	28.28
Tangible Book Value	1.49B	-666M	-420M	-401M	-643M
Tangible Book Value Per Share	35.83	-10.03	-6.3	-5.95	-9.47
Total Debt	139M	2.85B	2.62B	2.68B	2.85B
Net Debt	-727M	2.47B	2.45B	2.58B	2.68B
Debt Equivalent of Unfunded Proj. Benefit Obligation	-	13.3M	16.5M	13.7M	14.4M
Debt Equivalent Oper. Leases	123M	256M	386M	429M	378M
Account Code - Inventory Valuation	5	5	5	5	5
Inventories - Raw Materials, Total	103M	-	-	-	-
Inventories - Work In Process, Total	36.09M	-	-	-	-
Inventories - Finished Goods, Total	59.52M	-	-	-	-
Land - (BS)	10.18M	34.5M	34.7M	11.7M	15.1M
Buildings, Total	147M	365M	400M	330M	333M
Machinery, Total	227M	950M	1.2B	1.4B	1.68B
Full Time Employees	1.6K	7K	7.1K	6.6K	6.5K
Accumulated Allowance for Doubtful Accounts (Supple)	52.42M	12M	14.6M	14.3M	17.3M

Fiscal Period: December	2021	2022	2023	2024	2025
Net Income	704M	549M	-10.1M	-2.05B	-1.13B
Depreciation & Amortization - CF	26.98M	151M	252M	250M	253M
Amortization of Goodwill and Intangible Assets - (CF)	26.4M	132M	204M	201M	186M
Depreciation & Amortization, Total	53.38M	283M	457M	451M	438M
Amortization of Deferred Charges, Total - (CF)	1.4M	900K	600K	2.7M	3.6M
Asset Writedown & Restructuring Costs	-	-	-	1.9B	863M
Stock-Based Compensation (CF)	25.41M	48.4M	51.6M	42.1M	45.9M
Other Operating Activities, Total	24.23M	57.8M	-23.6M	-101M	12.3M
Change In Accounts Receivable	119M	150M	160M	5.4M	-118M
Change In Inventories	-85.04M	-117M	-212M	-134M	-148M
Change In Accounts Payable	10.45M	23.5M	3M	-23.4M	40M
Change in Unearned Revenues	-	-	-	-	-
Change In Income Taxes	-66.69M	-26.8M	-59.6M	-9.5M	41.7M
Change in Other Net Operating Assets	19.65M	-83.2M	-86.7M	2.9M	58.3M
Cash from Operations	806M	885M	280M	83M	105M
Capital Expenditure	-293M	-141M	-209M	-195M	-188M
Sale of Property, Plant, and Equipment	-	-	-	9.3M	-
Cash Acquisitions	-	-1.51B	-	-	-
Investment in Marketable and Equity Securities, Total	-63.69M	-10.3M	18.2M	55.9M	-
Net (Increase) Decrease in Loans Originated / Sold - Investing	-	-	-	-	-11M
Other Investing Activities, Total	36.88M	18.4M	3.5M	-20M	6.5M
Cash from Investing	-320M	-1.64B	-188M	-150M	-193M
Short Term Debt Issued, Total	-	-	1.6M	198M	3M
Long-Term Debt Issued, Total	-	2.73B	-	-	2.56B
Total Debt Issued	-	2.73B	1.6M	198M	2.56B
Short Term Debt Repaid, Total	-	-	-	-1.6M	-118M
Long-Term Debt Repaid, Total	-260K	-2.39B	-228M	-143M	-2.29B
Total Debt Repaid	-260K	-2.39B	-228M	-145M	-2.41B
Issuance of Common Stock	7.55M	26.4M	11.6M	5M	6.1M
Repurchase of Common Stock	-141M	-82.9M	-20.7M	-9.6M	-5.4M
Other Financing Activities, Total	-39.88M	-37.7M	-30.3M	-	-
Cash from Financing	-173M	252M	-266M	48.8M	156M
Foreign Exchange Rate Adjustments	-352K	-2M	-1.2M	-2.9M	3M
Net Change in Cash	313M	-509M	-174M	-21M	71.3M
Supplemental Items
Cash Interest Paid	-	95.1M	150M	178M	172M
Cash Income Tax Paid (Refund)	236M	265M	86.6M	41.6M	-25.4M
Levered Free Cash Flow	381M	640M	336M	212M	234M
Unlevered Free Cash Flow	384M	688M	450M	332M	351M
Change In Net Working Capital	-24.7M	140M	36.6M	17.7M	25.3M
Net Debt Issued / Repaid	-260K	346M	-226M	53.4M	155M

Fiscal Period: December	2021	2022	2023	2024	2025
Profitability
Return on Assets	26.61	10.99	2.01	0.65	1.27
Return on Total Capital	32.62	12.58	2.27	0.73	1.48
Return On Equity %	43.18	15.99	-0.2	-51.36	-46.15
Return on Common Equity	43.18	15.99	-0.2	-51.36	-46.15
Margin Analysis
Gross Profit Margin %	74.82	59.28	49.85	46.23	46.81
SG&A Margin	15.27	19.01	25.46	27.55	27.33
EBITDA Margin %	57.06	39.03	24.56	18.98	20.58
EBITA Margin %	55.47	34.4	16.14	10	11.33
EBIT Margin %	53.92	30.37	9.33	2.79	4.53
Income From Continuing Operations Margin %	41.46	16.8	-0.34	-73.74	-41.45
Net Income Margin %	41.46	16.8	-0.34	-73.74	-41.45
Net Avail. For Common Margin %	41.46	16.8	-0.34	-73.74	-41.45
Normalized Net Income Margin	33.49	17.38	2.32	-2.09	-1.37
Levered Free Cash Flow Margin	22.43	19.59	11.21	7.61	8.57
Unlevered Free Cash Flow Margin	22.62	21.06	15.01	11.91	12.87
Asset Turnover
Asset Turnover	0.79	0.58	0.34	0.37	0.45
Fixed Assets Turnover	4.94	3.27	1.91	1.76	1.78
Receivables Turnover (Average Receivables)	3.81	7.41	7.03	8.38	7.12
Inventory Turnover (Average Inventory)	2.74	3.68	2.73	2.69	2.61
Short Term Liquidity
Current Ratio	4.45	1.56	1.57	1.22	1.5
Quick Ratio	3.78	0.94	0.79	0.55	0.77
Operating Cash Flow to Current Liabilities	2.49	0.88	0.34	0.08	0.11
Days Sales Outstanding (Average Receivables)	95.81	49.12	51.79	43.45	51.1
Days Outstanding Inventory (Average Inventory)	133.38	98.92	133.39	135.19	139.28
Average Days Payable Outstanding	66.86	42.31	67.57	67.77	63.91
Cash Conversion Cycle (Average Days)	162.33	105.74	117.61	110.87	126.46
Long Term Solvency
Total Debt/Equity	7.22	57.78	52.36	89.84	148.6
Total Debt / Total Capital	6.73	36.62	34.37	47.33	59.77
LT Debt/Equity	6.68	53.08	49.03	77.35	137.79
Long-Term Debt / Total Capital	6.23	33.64	32.18	40.74	55.43
Total Liabilities / Total Assets	20.61	44.28	41.54	53.54	66.71
EBIT / Interest Expense	160.5	12.95	1.53	0.41	0.66
EBITDA / Interest Expense	172.55	17.06	4.31	3.04	3.24
(EBITDA - Capex) / Interest Expense	121.25	15.22	3.16	2.02	2.24
Total Debt / EBITDA	0.14	2.18	3.34	4.61	4.68
Net Debt / EBITDA	-0.74	1.89	3.12	4.44	4.4
Total Debt / (EBITDA - Capex)	0.2	2.45	4.56	6.93	6.78
Net Debt / (EBITDA - Capex)	-1.05	2.12	4.25	6.67	6.37
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	2.22	92.28	-8.21	-7.17	-1.89
Gross Profit, 1 Yr. Growth %	-5.78	51.45	-22.81	-14.07	-0.66
EBITDA, 1 Yr. Growth %	-12.97	31.78	-42.25	-28.68	12.92
EBITA, 1 Yr. Growth %	-13.7	19.28	-56.94	-43.01	24.83
EBIT, 1 Yr. Growth %	-14.04	8.34	-71.81	-72.69	162.98
Earnings From Cont. Operations, 1 Yr. Growth %	-13.09	-22.08	-101.84	20.22K	-44.84
Net Income, 1 Yr. Growth %	-13.09	-22.08	-101.84	20.22K	-44.84
Normalized Net Income, 1 Yr. Growth %	-13.89	-0.19	-87.73	-180.24	-51.62
Diluted EPS Before Extra, 1 Yr. Growth %	-11.66	-41.81	-101.58	20.1K	-45.34
Accounts Receivable, 1 Yr. Growth %	-26.43	33.2	-30.59	-9.9	43.44
Inventory, 1 Yr. Growth %	74.66	163.63	10.25	-7.63	8.23
Net Property, Plant and Equip., 1 Yr. Growth %	125.96	218.79	6.14	-4	-2.27
Total Assets, 1 Yr. Growth %	29.89	264.38	-3.31	-24.99	-10.19
Tangible Book Value, 1 Yr. Growth %	71.05	-144.59	-36.88	-4.71	60.58
Common Equity, 1 Yr. Growth %	44.77	155.76	1.44	-40.38	-35.65
Cash From Operations, 1 Yr. Growth %	27.96	9.85	-68.35	-70.38	26.75
Capital Expenditures, 1 Yr. Growth %	350.85	-51.88	48.54	-6.78	-3.54
Levered Free Cash Flow, 1 Yr. Growth %	-6.12	67.6	-47.5	-37.48	21.38
Unlevered Free Cash Flow, 1 Yr. Growth %	-6.39	79.94	-34.6	-26.77	12.44
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	78.2	40.19	32.85	-7.69	-4.57
Gross Profit, 2 Yr. CAGR %	99.04	19.47	8.12	-18.49	-7.61
EBITDA, 2 Yr. CAGR %	151.79	7.07	-12.76	-35.69	-11.26
EBITA, 2 Yr. CAGR %	166.62	1.51	-28.33	-50.29	-18.12
EBIT, 2 Yr. CAGR %	194.15	-3.44	-44.74	-72.07	-30.65
Earnings From Cont. Operations, 2 Yr. CAGR %	210.76	-17.71	-88.02	93.38	958.58
Net Income, 2 Yr. CAGR %	210.76	-17.71	-88.02	93.38	958.58
Normalized Net Income, 2 Yr. CAGR %	216.15	-7.19	-65.01	-68.05	-17.94
Diluted EPS Before Extra, 2 Yr. CAGR %	207.79	-28.3	-90.41	78.73	950.75
Accounts Receivable, 2 Yr. CAGR %	100	-1	-3.84	-20.92	13.68
Inventory, 2 Yr. CAGR %	84.98	114.6	70.48	0.91	-0.02
Net Property, Plant and Equip., 2 Yr. CAGR %	66.56	168.38	83.95	0.95	-3.14
Total Assets, 2 Yr. CAGR %	63.35	117.55	87.71	-14.83	-17.92
Tangible Book Value, 2 Yr. CAGR %	347.2	-12.67	-46.95	-22.44	23.7
Common Equity, 2 Yr. CAGR %	85.64	92.42	61.08	-22.23	-38.06
Cash From Operations, 2 Yr. CAGR %	144.79	18.57	-41.04	-69.38	-38.73
Capital Expenditures, 2 Yr. CAGR %	227.88	47.34	-15.45	17.67	-5.17
Levered Free Cash Flow, 2 Yr. CAGR %	126.82	25.12	-6.19	-42.55	-14.76
Unlevered Free Cash Flow, 2 Yr. CAGR %	116.82	29.64	8.48	-30.66	-10.22
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	48.16	82.78	21.74	17.89	-5.8
Gross Profit, 3 Yr. CAGR %	58.47	82.06	3.28	0.21	-12.93
EBITDA, 3 Yr. CAGR %	82.23	102.78	-12.84	-18.26	-23.95
EBITA, 3 Yr. CAGR %	87.61	103.9	-23.73	-33.4	-35.01
EBIT, 3 Yr. CAGR %	99.76	110.83	-35.95	-56.07	-50.1
Earnings From Cont. Operations, 3 Yr. CAGR %	111.74	95.96	-76.81	42.83	27.3
Net Income, 3 Yr. CAGR %	111.74	95.96	-76.81	42.83	27.3
Normalized Net Income, 3 Yr. CAGR %	115.76	115.25	-52.73	-53.24	-59.66
Diluted EPS Before Extra, 3 Yr. CAGR %	106.75	76.65	-79.89	22.95	20.42
Accounts Receivable, 3 Yr. CAGR %	86.06	74.66	-12.05	-5.91	-3.55
Inventory, 3 Yr. CAGR %	43.42	108.18	71.88	38.98	3.29
Net Property, Plant and Equip., 3 Yr. CAGR %	86.17	106.79	97	48.1	-0.14
Total Assets, 3 Yr. CAGR %	44.45	113.43	66.02	38.26	-13.31
Tangible Book Value, 3 Yr. CAGR %	158.51	107.37	-21.63	-35.51	-1.15
Common Equity, 3 Yr. CAGR %	65.5	106.57	55.45	15.65	-26.99
Cash From Operations, 3 Yr. CAGR %	80.8	87.42	-23.66	-53.13	-50.84
Capital Expenditures, 3 Yr. CAGR %	109.82	72.97	47.74	-12.66	10.13
Levered Free Cash Flow, 3 Yr. CAGR %	18.41	105.21	-6.33	-17.83	-28.57
Unlevered Free Cash Flow, 3 Yr. CAGR %	16.86	103.41	3.2	-4.64	-20.14
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	54.72	63.71	41.83	39.07	10.44
Gross Profit, 5 Yr. CAGR %	62.77	63.24	36.16	32.02	-1.18
EBITDA, 5 Yr. CAGR %	121.48	80.31	35.67	28.15	-12.76
EBITA, 5 Yr. CAGR %	187.62	84.73	27.66	15.99	-22.28
EBIT, 5 Yr. CAGR %	193.39	93.12	19.47	-6.02	-34.98
Earnings From Cont. Operations, 5 Yr. CAGR %	119.54	131.99	-32.89	94.92	6.91
Net Income, 5 Yr. CAGR %	119.54	131.99	-32.89	94.92	6.91
Normalized Net Income, 5 Yr. CAGR %	123.3	115.95	4.22	0.42	-43.67
Diluted EPS Before Extra, 5 Yr. CAGR %	107.99	108.6	-39.46	77.48	-2.13
Accounts Receivable, 5 Yr. CAGR %	72.16	46.52	42.89	27.22	-2.54
Inventory, 5 Yr. CAGR %	50.15	50.86	53.69	55.83	38.39
Net Property, Plant and Equip., 5 Yr. CAGR %	56.46	89.88	85.28	55.22	48.3
Total Assets, 5 Yr. CAGR %	44.32	56.77	60.41	47.8	25.26
Tangible Book Value, 5 Yr. CAGR %	75.72	16.25	37.2	39.92	-5.93
Common Equity, 5 Yr. CAGR %	57.25	85.1	63.72	39.75	7.58
Cash From Operations, 5 Yr. CAGR %	132.68	99.94	15.5	-9.2	-30.08
Capital Expenditures, 5 Yr. CAGR %	89.72	51.75	45.87	48.27	23.73
Levered Free Cash Flow, 5 Yr. CAGR %	102.12	38.79	7.92	23.39	-10.57
Unlevered Free Cash Flow, 5 Yr. CAGR %	96.79	41.96	13.32	32.32	-3.01